Home › NDC Lookup › RxCUI directory › RxCUI 2723913

10 ML ketamine 10 MG/ML Prefilled Syringe — RxCUI 2723913

RxNorm drug concept · Semantic clinical drug
RxCUI 2723913 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2723913
Official name10 ML ketamine 10 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asketamine 100 MG (as ketamine hydrochloride 115.3 MG) per 10 ML Prefilled Syringe; ketamine 100 MG in 10 ML Prefilled Syringe
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ketamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ketamine is a general anesthetic. It is used alone for certain diagnostic and surgical procedures, to start anesthesia before other anesthetics, or to add to them. It is given by t...
  • It is given as an injection into a vein or a muscle. Your care team adjusts the dose to you and monitors your vital signs the whole time. You will be told whether to avoid eating o...
  • Some people feel confused or agitated, or have vivid dreams or hallucinations as the drug wears off. This happened in about 12% of patients and usually lasts a few hours. A quiet,...
  • Tell your team about everything you take. Opioids, benzodiazepines, other sedating medicines, and alcohol can cause deep sedation and dangerously slow breathing. Theophylline and a...
📖 Read our full Ketamine guide →

🕸️ Concept Web — How 10 ML ketamine 10 MG/ML Prefilled Syringe Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 10 ML ketamine 10 MG/ML Prefilled Syringe RxCUI 2723913

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ketamine 6130
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ketamine Prefilled Syringe 2723912
    • Ketamine Injectable Product 1160946
    • Prefilled Syringe 721656
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ketamine 10 MG/ML 330467

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ketamine 10 MG/ML SCDC · 330467
  • Ketamine Prefilled Syringe SCDF · 2723912
  • Ketamine Injectable Product SCDG · 1160946

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2723913 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
43066-0177-05 5 CARTON in 1 CARTON (43066-177-05) / 1 SYRINGE, PLASTIC in... KETAMINE HYDROCHLORIDE Baxter Healthcare Corporation 2025-09-17
Observed labelers: Baxter Healthcare Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.